Bringing the fundamentals into focus…
Back to NeoGenomics, Inc.
How NeoGenomics, Inc. stacks up
NEO · against 387 other Healthcare companies of similar size
Profitability
31/ 100
Below the middle of the pack.
Ranked #284 of 388 · scores higher than 26% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 30–39, including NEO · Click a bar to see the companies
Why profitability scores 31?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 74% of peers. Operating margin: -8.9% vs peer median 7.1%
- a lower return on invested capital: weaker than 72% of peers. Return on invested capital: -5.3% vs peer median 4.7%
- a lower return on assets: weaker than 68% of peers. Return on assets: -3.8% vs peer median 1.7%
Metric by metric
Position: dot = NEO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NEO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 365 reported | -5.3% | 6.1% | 24% | 33% | |
| Operating marginHigher is better · 358 reported | -8.9% | 8.4% | 22% | 33% | |
| Return on assetsHigher is better · 372 reported | -3.8% | 2.1% | 28% | 33% | |
| Return on equityHigher is better · 357 reported | -6.3% | 5.2% | 32% | Context only | |
| Gross marginHigher is better · 402 reported | 43.9% | 48.8% | 45% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NEO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 280 | 2.0B USD | 32 | 44 | |
| 280 | 1.6B USD | 32 | 29 | |
| 284 | 24.9B CNY (≈$3.5B) | 31 | 38 | |
| 284 | 8.9B HKD (≈$1.1B) | 31 | 61 | |
| 284 | 2.2B USD | 31 | 36 | |
| 284 | 1.3B USD | 31 | 20 | |
| 288 | 2.8B USD | 30 | 33 | |
| 288 | 1.2B USD | 30 | 24 | |
| 290 | 2.9B USD | 29 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score